文献速递泌尿生殖MRUS

前列腺靶向穿刺活检

Targeted biopsy of the prostate.
PubMed 文献 · Abdom Radiol (NY) · 2024-07-08

本文综述前列腺靶向穿刺活检的现状,重点比较不同技术的相对准确性。多参数MRI可可靠显示多数前列腺癌患者的主要肿瘤,软件辅助MRI-超声融合活检与直接MRI引导的孔内活检已获成功测试,传统盲法系统活检正逐渐被MRI引导的靶向活检取代,多项大型多中心试验结果已呈现,同时提出有待更多研究的问题。

要点

  • 多参数MRI可可靠显示多数前列腺癌患者的主要肿瘤病灶。
  • 软件辅助MRI-超声融合活检和直接MRI引导的孔内活检是已成功测试的靶向穿刺方法。
  • 传统盲法系统活检正日益被MRI引导的靶向活检取代。

核心结论

  • 前列腺癌诊断方法正发生根本性转变,传统盲法系统活检日益被MRI引导的靶向活检取代;本综述描述靶向活检现状,重点在于不同技术的相对准确性,并指出有待更多研究的问题。

研究设计与样本

  • 综述,旨在描述靶向活检的现状,重点比较不同技术的相对准确性,并呈现多项关键大型多中心试验的结果。

局限性

  • 原文指出仍存在有待更多研究的问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Diagnostic multiparametric MRI of the prostate has steadily evolved over the last three decades and can now reliably depict the dominant tumor in most men with prostate cancer. In response, several methods of targeted biopsy to direct tissue sampling of suspected tumor foci seen at multiparametric MRI have been developed and successfully tested in recent years, including software-assisted MRI-ultrasound (US) fusion biopsy and direct MRI-guided in-bore biopsy. These advances are leading to a sea change in the approach to prostate cancer diagnosis, with the traditional approach of blind systematic biopsy increasingly being replaced by MRI directed targeted biopsy. This review aims to describe the current status of targeted biopsy, with an emphasis on the relative accuracy of different techniques. The results of several critical large multicenter trials are presented, while unanswered questions that require more research are highlighted.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Schroeder DW, Foster BR, Young DJ, et al. Targeted biopsy of the prostate. Abdom Radiol (NY). 2024. PMID: 38976055. doi:10.1007/s00261-024-04452-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。